SCTX (SCTX) Stock Price & Analysis
SCTX (SCTX) fell 6.95% to USD 28.67 as of September 8, 2026 at 12:49 UTC, according to Nexqual real-time market data.
SCTX last closed at USD 28.67; the session ranged USD 28.5–31.41 on volume of 148,197 shares. Market capitalization is —, with a 52-week range of USD 17.31–39.6 (NGM). Source: Nexqual, September 8, 2026 at 12:49 UTC.
Key Statistics (as of September 8, 2026 at 12:49 UTC)
| Price | USD 28.67 |
|---|---|
| Change | ▼ 6.95% (down) |
| Previous Close | USD 28.67 |
| Open | USD 28.67 |
| Day Range | USD 28.5 – 31.41 |
| 52-Week Range | USD 17.31 – 39.6 |
| Volume | 148,197 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (SCTX)
Nexqual's technical model rates SCTX "BUY" based on 3 bullish and 0 bearish signals across 30 daily candles, as of September 8, 2026 at 12:49 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 54.44 (neutral) |
| MACD | 2.93 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BRVE | Braveheart Bio, Inc. | USD 26.74 | ▼ 0.78% |
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| KLRA | Kailera Therapeutics, Inc. | USD 16.23 | ▲ 2.4% |
| APMD | Apnimed, Inc. | USD 27.45 | ▼ 1.37% |
| PBLS | Parabilis Medicines, Inc. | USD 40.42 | ▲ 0.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:49 UTC. This page is informational and not investment advice.